GSK provides update on phase-III RSV maternal vaccine candidate
The company has decided to stop enrollment and vaccination in trials evaluating its potential Respiratory Syncytial Virus (RSV)…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.